Yıl: 2020 Cilt: 31 Sayı: 9 Sayfa Aralığı: 640 - 648 Metin Dili: İngilizce DOI: 10.5152/tjg.2020.19434 İndeks Tarihi: 05-05-2021

Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography

Öz:
Background/aims: Pancreatic steatosis (PS) is a subject of current interest and its prevalence has been reported to range from 16.1% to 30.7% using various radiological methods. This study aimed to evaluate PS prevalence with non-contrast computed tomography (CT).Materials and methods: The non-contrast CT scans taken in 2016 and 2017 in our hospital were retrospectively screened. A total of 637 cases (320 males, 317 females) were included in the study. CT number measurements were performed from three anatomic regions of the pancreas using regions of interest (ROI) of approximately 1 cm2. The cases with a <0.7 ratio of the pancreatic over splenic CT number were accepted as quantitatively steatosis-positive. Anthropometric evaluations were undertaken by determining various parameters defined on CT.Results: PS was determined visually in 30.6% of the males and 29% of the females, and quantitatively in 32.8% and 30.6%, respectively. A positive agreement was determined between the quantitative and visual evaluations of steatosis (Cohen's kappa coefficient=0.587, p<0.001). Although PS was seen to be mostly diffuse, the tail region of the pancreas was determined to be the area with most steatosis.Conclusion: PS is usually overlooked in radiology practice but it has a clinical presentation with non-insignificant prevalence. Current radiological methods are adequate in the evaluation of PS. The determination of the cut-off values for various criteria on non-contrast CT can provide more objective evaluations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ogilvie RF. The islands of Langerhans in 19 cases of obesity. The Journal of Pathology and Bacteriology 1933; 37: 473-81. [Crossref]
  • 2. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 1978; 86a: 367-73. [Crossref]
  • 3. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol 1984; 15: 677-83. [Crossref]
  • 4. Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 2011; 8: 169-77. [Crossref]
  • 5. Alempijevic T, Dragasevic S, Zec S, Popovic D, Milosavljevic T. Non-alcoholic fatty pancreas disease. Postgrad Med J 2017; 93: 226-30. [Crossref]
  • 6. Hori M, Takahashi M, Hiraoka N, et al. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol 2014; 5: e53. [Crossref]
  • 7. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 2007; 246: 1058-64. [Crossref]
  • 8. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013; 267: 767-75. [Crossref]
  • 9. Pickhardt PJ, Graffy PM, Reeder SB, Hernando D, Li K. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction. Am J Roentgenol 2018; 211: 151-7. [Crossref]
  • 10. Graffy PM, Sandfort V, Summers RM, Pickhardt PJ. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment. Radiology 2019; 293: 334-42. [Crossref]
  • 11. Chouhan MD, Firmin L, Read S, Amin Z, Taylor SA. Quantitative pancreatic MRI: a pathology-based review. Br J Radiol 2019; 92: 20180941. [Crossref]
  • 12. Koc U, Taydas O. Investigation of the relationship between fatty pancreas and cholecystectomy using noncontrast computed tomography. J Med Imaging Radiat Sci 2019; 50: 220-6. [Crossref]
  • 13. Koc U, Ocakoglu G, Algın O. The Efficacy of the 3-dimensional VIBE-CAIPIRINHA-Dixon technique in the Evaluation of Pancreatic Steatosis. Turk J Med Sci 2020; 50: 184-94.
  • 14. Tahtaci M, Algin O, Karakan T, et al. Can pancreatic steatosis affect exocrine functions of pancreas? Turk J Gastroenterol 2018; 29: 588-94. [Crossref]
  • 15. Miyake H, Sakagami J, Yasuda H, et al. Association of fatty pancreas with pancreatic endocrine and exocrine function. PLoS One 2018; 13: e0209448. [Crossref]
  • 16. Della Corte C, Mosca A, Majo F, et al. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) 2015; 83: 656-62. [Crossref]
  • 17. Kaya E, Yilmaz Y. Non-alcoholic fatty liver disease: A growing public health problem in Turkey. Turk J Gastroenterol 2019; 30: 865-71. [Crossref]
  • 18. Yilmaz Y, Kani HT, Demirtas CO, et al. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. Turk J Gastroenterol 2019; 30: 892-8. [Crossref]
  • 19. Fukuda Y, Yamada D, Eguchi H, et al. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2017; 24: 2762-9. [Crossref]
  • 20. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007; 20: 933-42. [Crossref]
  • 21. Chantarojanasiri T, Hirooka Y, Ratanachu-Ek T, Kawashima H, Ohno E, Goto H. Evolution of pancreas in aging: degenerative variation or early changes of disease? J Med Ultrason 2015; 42: 177-83. [Crossref]
  • 22. Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterology Res 2016; 9: 87-91. [Crossref]
  • 23. Lesmana CRA, Gani RA, Lesmana LA. Non-alcoholic fatty pancreas disease (NAFPD) as risk factor for pancreatic cancer based on endoscopic ultrasound (EUS) examination: a single center experience. JGH Open 2017; 152: 4-7. [Crossref]
  • 24. Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 2014; 271: 104-12. [Crossref]
  • 25. Wong VW, Wong GL, Yeung DK, et al. Fatty pancreas, insulin resistance, and beta-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol 2014; 109: 589-97. [Crossref]
  • 26. Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 37: 630-9. [Crossref]
  • 27. Zhou J, Li ML, Zhang DD, et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology 2016; 16: 578-83. [Crossref]
  • 28. Takahashi M, Hori M, Ishigamori R, Mutoh M, Imai T, Nakagama H. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Sci 2018; 109: 3013-23. [Crossref]
  • 29. Hori M, Onaya H, Hiraoka N, et al. Evaluation of the degree of pancreatic fatty infiltration by area-based assessment of CT images: comparison with histopathology-based and CT attenuation index-based assessments. Jpn J Radiol 2016; 34: 667-76. [Crossref]
  • 30. Nahm CB, Lui I, Naidoo CS, et al. Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy. HPB (Oxford) 2019; 21: 604-11. [Crossref]
  • 31. Geraghty EM, Boone JM. Determination of height, weight, body mass index, and body surface area with a single abdominal CT image. Radiology 2003; 228: 857-63. [Crossref]
  • 32. Gaba RC, Knuttinen MG, Brodsky TR, et al. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results. Diagn Interv Radiol 2012; 18: 282-7. [Crossref]
APA Koc U, Taydas O (2020). Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. , 640 - 648. 10.5152/tjg.2020.19434
Chicago Koc Ural,Taydas Onur Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. (2020): 640 - 648. 10.5152/tjg.2020.19434
MLA Koc Ural,Taydas Onur Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. , 2020, ss.640 - 648. 10.5152/tjg.2020.19434
AMA Koc U,Taydas O Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. . 2020; 640 - 648. 10.5152/tjg.2020.19434
Vancouver Koc U,Taydas O Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. . 2020; 640 - 648. 10.5152/tjg.2020.19434
IEEE Koc U,Taydas O "Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography." , ss.640 - 648, 2020. 10.5152/tjg.2020.19434
ISNAD Koc, Ural - Taydas, Onur. "Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography". (2020), 640-648. https://doi.org/10.5152/tjg.2020.19434
APA Koc U, Taydas O (2020). Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. Turkish Journal of Gastroenterology, 31(9), 640 - 648. 10.5152/tjg.2020.19434
Chicago Koc Ural,Taydas Onur Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. Turkish Journal of Gastroenterology 31, no.9 (2020): 640 - 648. 10.5152/tjg.2020.19434
MLA Koc Ural,Taydas Onur Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. Turkish Journal of Gastroenterology, vol.31, no.9, 2020, ss.640 - 648. 10.5152/tjg.2020.19434
AMA Koc U,Taydas O Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. Turkish Journal of Gastroenterology. 2020; 31(9): 640 - 648. 10.5152/tjg.2020.19434
Vancouver Koc U,Taydas O Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography. Turkish Journal of Gastroenterology. 2020; 31(9): 640 - 648. 10.5152/tjg.2020.19434
IEEE Koc U,Taydas O "Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography." Turkish Journal of Gastroenterology, 31, ss.640 - 648, 2020. 10.5152/tjg.2020.19434
ISNAD Koc, Ural - Taydas, Onur. "Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography". Turkish Journal of Gastroenterology 31/9 (2020), 640-648. https://doi.org/10.5152/tjg.2020.19434